Allen Wolff

Allen Wolff is recorded as Chairman at Ernexa Therapeutics Inc. (ERNA) since April 2, 2020 and Board Member at Ernexa Therapeutics Inc. (ERNA) since January 14, 2020. The proxy statement of Ernexa Therapeutics Inc. reports total compensation of $594,040 for Allen Wolff in fiscal 2020, including a base salary of $322,213. Disclosed compensation is on record for 2 fiscal years. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Dr. Matthew Angel (CEO), Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member) and 7 others.